Skip to main content

Table 3 Concentration and conformational characteristics of Tau isoforms in AD cases

From: Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer’s disease tau

AD case

Total soluble tau

Insoluble total tau

Insoluble 3R tau

Insoluble 4R tau

3R/4R tau ratio

Units

µg/ml

µg/ml

CDI D/N ratio

µg/ml

CDI D/N ratio

µg/ml

CDI D/N ratio

3R (%)

4R (%)

AD 1

10.9

9.2

73.8

1.0

32.2

8.2

87.7

11.0

89.0

AD 2

8.3

4.1

50.1

0.6

17.1

3.6

72.6

13.8

86.2

AD 3

16.0

10.1

39.4

1.3

20.9

8.7

45.6

13.3

86.7

AD 4

9.5

5.1

49.5

0.6

24.2

4.5

57.5

11.8

88.2

AD 5

8.5

15.1

34.4

1.8

42.4

13.3

33.5

11.9

88.1

AD 6

5.4

1.3

13.6

0.3

6.0

1.0

21.1

21.8

78.2

Mo C57Bl

15.1

0.094

0.7

0.001

0.8

0.093

0.7

1.6

98.4

  1. The concentrations of Sarkosyl-soluble and insoluble tau were obtained with CDI in duplicate measurements and are expressed in µg/ml of 10% brain homogenate